Systems‐based digital twins to help characterize clinical <scp>dose–response</scp> and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in <scp>NHL</scp>Monica Susilo, Iraj Hosseini, Kapil Gadkar et al.|Clinical and Translational Science|2023Cited by 74